Mark W. Bêcher

6.2k total citations · 2 hit papers
44 papers, 4.7k citations indexed

About

Mark W. Bêcher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Mark W. Bêcher has authored 44 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 14 papers in Neurology. Recurrent topics in Mark W. Bêcher's work include Genetic Neurodegenerative Diseases (14 papers), Mitochondrial Function and Pathology (10 papers) and Neurological disorders and treatments (7 papers). Mark W. Bêcher is often cited by papers focused on Genetic Neurodegenerative Diseases (14 papers), Mitochondrial Function and Pathology (10 papers) and Neurological disorders and treatments (7 papers). Mark W. Bêcher collaborates with scholars based in United States, United Kingdom and Germany. Mark W. Bêcher's co-authors include Donald L. Price, Sangram S. Sisodia, Don W. Cleveland, Lucie Bruijn, Michael K. Lee, David Borchelt, Neal G. Copeland, Jeffrey D. Rothstein, Kenton L. Anderson and N.A. Jenkins and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark W. Bêcher

41 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

1997 1.1k citations Lucie Bruijn, Mark W. Bêcher et al. Neuron profile →
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm

1997 591 citations Philip C. Wong, Mark W. Bêcher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark W. Bêcher United States	23	2.3k	1.9k	1.9k	866	732	44	4.7k
Manabu Doyu Japan	42	4.1k 1.7×	2.5k 1.3×	3.4k 1.8×	804 0.9×	1.4k 1.9×	107	6.8k
Antonio Migheli Italy	39	2.6k 1.1×	1.2k 0.6×	1.1k 0.6×	2.4k 2.8×	787 1.1×	83	6.1k
Hidefumi Ito Japan	38	1.5k 0.6×	1.7k 0.9×	838 0.5×	785 0.9×	564 0.8×	145	3.9k
Natalia Ninkina United Kingdom	38	1.8k 0.7×	2.1k 1.1×	1.4k 0.8×	988 1.1×	250 0.3×	103	4.3k
Andrew G. Reaume United States	28	3.8k 1.6×	1.7k 0.9×	730 0.4×	1.3k 1.5×	803 1.1×	40	6.5k
Frank Gillardon Germany	37	2.2k 0.9×	1.5k 0.8×	1.5k 0.8×	1.0k 1.2×	166 0.2×	98	4.6k
Masaaki Matsuoka Japan	34	2.5k 1.1×	805 0.4×	814 0.4×	1.2k 1.4×	409 0.6×	107	4.5k
Bradley Smith United Kingdom	30	2.2k 1.0×	2.1k 1.1×	504 0.3×	744 0.9×	1.1k 1.5×	72	4.5k
Jean-Pierre Julien Canada	17	1.3k 0.5×	1.5k 0.8×	663 0.4×	953 1.1×	753 1.0×	20	4.6k
Smita Saxena Switzerland	22	1.5k 0.6×	1.4k 0.7×	1.1k 0.6×	512 0.6×	774 1.1×	40	3.6k

Countries citing papers authored by Mark W. Bêcher

Since Specialization

Citations

This map shows the geographic impact of Mark W. Bêcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Bêcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Bêcher more than expected).

Fields of papers citing papers by Mark W. Bêcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Bêcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Bêcher. The network helps show where Mark W. Bêcher may publish in the future.

Co-authorship network of co-authors of Mark W. Bêcher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Bêcher. A scholar is included among the top collaborators of Mark W. Bêcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Bêcher. Mark W. Bêcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woletz, Michael, Mark W. Bêcher, Jonas Björklund, et al.. (2025). Reducing target E-field variability in repetitive TMS through online motion compensation. Brain stimulation. 19(1). 102990–102990.

Bêcher, Mark W.. (2011). Practical Neuropathology Synoptic Reporting for Central Nervous System Tumors. Archives of Pathology & Laboratory Medicine. 135(6). 789–792. 2 indexed citations

Mankodi, Ami, et al.. (2011). Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy. Neurobiology of Disease. 45(1). 539–546. 17 indexed citations

Ehtesham, Moneeb, J. Gerardo Valadez, Mark W. Bêcher, et al.. (2007). Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene. 26(39). 5752–5761. 114 indexed citations

Bêcher, Mark W., Ty W. Abel, Reid C. Thompson, Kyle D. Weaver, & Larry E. Davis. (2006). Immunohistochemical Analysis of Metastatic Neoplasms of the Central Nervous System. Journal of Neuropathology & Experimental Neurology. 65(10). 935–944. 21 indexed citations

Miller, G G, Guy Boivin, J. Stephen Dummer, et al.. (2006). Cytomegalovirus Ventriculoencephalitis in a Peripheral Blood Stem Cell Transplant Recipient. Clinical Infectious Diseases. 42(4). e26–e29. 21 indexed citations

Davis, Larry E., et al.. (2004). Persistent Choreoathetosis in a Fatal Olanzapine Overdose: Drug Kinetics, Neuroimaging, and Neuropathology. American Journal of Psychiatry. 162(1). 28–33. 9 indexed citations

Karpuj, Marcela V., Mark W. Bêcher, Joe E. Springer, et al.. (2002). Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nature Medicine. 8(2). 143–149. 320 indexed citations

Karpuj, Marcela V., Mark W. Bêcher, & Lawrence Steinman. (2002). Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications. Neurochemistry International. 40(1). 31–36. 51 indexed citations

10.

Bêcher, Mark W., Marcia L. Wills, Walter W. Noll, Orest Hurko, & Donald L. Price. (1999). Kearns-Sayre syndrome with features of Pearson's marrow-pancreas syndrome and a novel 2905-base pair mitochondrial DNA deletion. Human Pathology. 30(5). 577–581. 22 indexed citations

11.

Bêcher, Mark W., Alan H. Sharp, Stephen W. Davies, et al.. (1998). Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length. Neurobiology of Disease. 4(6). 387–397. 347 indexed citations

12.

Borchelt, David, Philip C. Wong, Mark W. Bêcher, et al.. (1998). Axonal Transport of Mutant Superoxide Dismutase 1 and Focal Axonal Abnormalities in the Proximal Axons of Transgenic Mice. Neurobiology of Disease. 5(1). 27–35. 81 indexed citations

13.

Margolis, Russell L., et al.. (1998). Chapter 28 Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: New answers, new questions. Progress in brain research. 117. 397–419. 31 indexed citations

14.

Bruijn, Lucie, Mark W. Bêcher, Michael K. Lee, et al.. (1997). ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions. Neuron. 18(2). 327–338. 1084 indexed citations breakdown →

15.

Bêcher, Mark W., David C. Rubinsztein, Jayne Leggo, et al.. (1997). Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees. Movement Disorders. 12(4). 519–530. 72 indexed citations

16.

Ross, Christopher A., Russell L. Margolis, Adam Rosenblatt, et al.. (1997). Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA). Medicine. 76(5). 305–338. 88 indexed citations

17.

Price, Donald L., Mark W. Bêcher, Philip C. Wong, et al.. (1996). Inherited Neurodegenerative Diseases and Transgenic Models. Brain Pathology. 6(4). 467–480. 10 indexed citations

18.

Marszalek, Joseph R., Toni Williamson, Michael K. Lee, et al.. (1996). Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport.. The Journal of Cell Biology. 135(3). 711–724. 150 indexed citations

19.

Bêcher, Mark W. & Miguel Marín‐Padilla. (1992). Intrinsic Laryngeal Muscle Regeneration Following Endotracheal Intubation. Pediatric Pathology. 12(2). 155–166. 1 indexed citations

20.

Bêcher, Mark W., et al.. (1990). [Quantitative study of the dendritic spins of lamina V pyramidal neurons of the frontal lobe in children with severe mental retardation].. PubMed. 31(2). 181–92. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact